Pakistan presents a very precarious scenario vis-à-vis heart attacks, heart failures and other cardiac ailments as these are the leading cause of deaths in our country. Every hour, 46 people die in Pakistan due to cardiac ailments. While there is an ever-growing national demand for cardiovascular devices and implants, Pakistan is completely dependent on imported cardiac devices. Because of their exorbitant costs, the imported devices are accessible by only 20% of the diseased population, rendering the remaining 80% deprived of treatment that can improve their health and life expectancy.

Instituted, under special directives of the Prime Minister’s Office and Supreme Court of Pakistan, at National University of Sciences & Technology (NUST), Islamabad, N-ovative Health Technologies (NHT) Pvt Ltd is dedicated to create healthcare solutions that meet the immediate demand of the country, with a special emphasis on saving precious foreign exchange, amounting to PKR 8.5 billion, on cardiac stent and catheter imports every year, and on the generation of foreign exchange through exports.

NHT is a state-of-the-art medical device manufacturing facility actively working in research and development of healthcare technologies as well as mass production of life-saving medical devices and implants such as Bare Metal stents, Drug-Eluting Stents, Angioplasty Balloon Catheters, Diagnostic Angiographic Catheters, ventilators etc, to be made available at a fraction of prices of their imported versions.

Sponsored by the Ministry of Sciences & Technology (MoST) with the mandate of indigenously manufacturing cost-effective high-quality medical devices, the facility is established as a public sector company with the Securities Exchange & Commission of Pakistan (SECP). NHT is ISO 13485:2016 certified from European Commission Notified Body and is approved by Drug Regulatory Authority of Pakistan (DRAP).

Board of Directors

Management